Zuellig Pharma Acquires Hangzhou Facility to Expand Chinese Clinical Sourcing
Healthcare distribution firm Zuellig Pharma acquired a licensed facility in Hangzhou to establish local clinical trial supply and sourcing capabilities across mainland China
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.